2020 Cardiac Disorders

Scheme description
Molecular testing for disorders associated with arrhythmia, cardiomyopathies and aortic dissection.
Disorders/Gene target(s)
Brugada syndrome
Long QT syndrome
Catecholaminergic polymorphic ventricular tachycardia (CPVT)
general arrhythmia
cardiomyopathies
Marfan syndrome
Clinical cases
Four
Testing/analysis
Gene panel, single gene and familial/predictive testing.
Sample type
DNA in EDTA
Techniques
Testing can be performed using any methodology.
Assessment
Submit a clinical report to include:
• Genotyping of results
• Interpretation of the result
• Clerical accuracy
Performance criteria are applied.
Eligibility
Any laboratory worldwide
Languages
English
ISO17043 Accredited EQA
Yes
EQA timeline
Sample dispatchMay 2020
Testing period16 weeks
Assessment resultsOctober 2020
Final Summary reportDecember 2020
Other information
Submit Gene panel details in the Targets Tested form.
If your laboratory does not routinely test for all of these diseases, then please contact GenQA.
The cases always include different disorders so you will be able to participate.
Fee
£375.00
GenQA code
2020CARD
« Return to EQA scheme list
Go to top